SCHEMBL3969374

SCHEMBL3969374

Cc1cnc(NCCCN2CCNCC2)nc1-c1cc2ccccc2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.41
IKBKB O14920 2/20 0.40
MERTK Q12866 2/20 0.38
FLT3 P36888 1/20 0.38
TYRO3 Q06418 1/20 0.38
GAS6 Q14393 1/20 0.38
DYRK2 Q92630 1/20 0.38
HRH3 Q9Y5N1 2/20 0.38
SIK2 Q9H0K1 1/20 0.38
STK26 Q9P289 1/20 0.38
STK24 Q9Y6E0 1/20 0.38
CCNT1 O60563 1/20 0.37
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK7 P50613 1/20 0.37
CDK9 P50750 1/20 0.37
CCNH P51946 1/20 0.37
STK17A Q9UEE5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3963837 0.90 FGFR1 (0.44) FGFR1EGFRSRCFGFR2FGFR4
SCHEMBL3965330 0.90 SLC2A1 (0.43) MERTKHRH3FGFR1EGFRSRC
SCHEMBL3971053 0.90 SLC2A1 (0.43) MERTKHRH3FGFR1EGFRSRC
Hydrochloric Acid SCHEMBL3964469 0.88 MERTK (0.36) LCKIKBKBMERTKFLT3TYRO3
Hydrochloric Acid SCHEMBL3962400 0.88 SIK2 (0.39) LCKIKBKBMERTKFLT3TYRO3
SCHEMBL3971739 0.87 VCP (0.46) MERTKDYRK2HRH3FGFR1EGFR
Hydrochloric Acid SCHEMBL3964380 0.84 TACR2 (0.38) MERTKFLT3GAS6HRH3FGFR1
SCHEMBL4084708 0.84 FGFR1 (0.39) LCKIKBKBSIK2STK26STK24
Hydrochloric Acid SCHEMBL3967074 0.83 DYRK2 (0.37) LCKIKBKBMERTKTYRO3GAS6
Hydrochloric Acid SCHEMBL3970371 0.82 CA1 (0.40) IKBKBMERTKCHEK1EGFRDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1989200-B1 [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES LILLY CO ELI (US) 2009-07-29 EP disclosed
US-7547691-B2 [4-(Benzo[B]thiophen-2-yl) Pyrimidin-2-yl]-amine derivatives as IKK-beta inhibitors for the treatment of cancer and inflammatory diseases ELI LILLY AND COMPANY (US) 2009-06-16 US disclosed
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases ELI LILLY AND COMPANY 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306082-A1 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases NFKBIA, IKBKB, IKBKG LCK 175/4885IKBKB 2/4885MERTK 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.